T 2362/19 (T cell expansion/ALLOVIR) of 23.02.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T236219.20220223
- Date of decision
- 23 February 2022
- Case number
- T 2362/19
- Petition for review of
- -
- Application number
- 12815750.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PROCESS FOR T CELL EXPANSION
- Applicant name
- AlloVir, Inc.
Baylor College of Medicine - Opponent name
- Strawman Limited
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Main request - admitted - (yes)
Added matter - (no)
Clarity - (yes)
Sufficiency of disclosure - (yes)
Novelty - (yes)
Inventive step - (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of claims 1 to 14 of the main request as submitted during the oral proceedings before the board, and a description to be adapted.